Evidence map›Paper›PMID 22923574›Full record

ArticleScience (New York, N.Y.)2012

A periciliary brush promotes the lung health by separating the mucus layer from airway epithelia.

Brian Button, Li-Heng Cai, Camille Ehre, Mehmet Kesimer, David B Hill, John K Sheehan, Richard C Boucher, Michael Rubinstein

Registry-linked trialAbstract read
In one paragraph

Article in Science (New York, N.Y.), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05392855 (Symptom Based Performance of Airway Clearance Therapy After Starting Highly Effective CFTR Modulator Therapy for Cystic Fibrosis), which is not on this map. Cited by 447 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
447citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05392855 naterminatednot on this mapstarted 2023, after this paper: background citation

Symptom Based Performance of Airway Clearance Therapy After Starting Highly Effective CFTR Modulator Therapy for Cystic Fibrosis

TypeinterventionalSponsorUniversity of Missouri-ColumbiaRan2023 to 2024Enrolled6ConditionsCystic Fibrosis, Mucociliary Clearance DefectArmsSymptom driven performance of airway clearance, Continuous daily performance of airway clearance
3 · Its place in the literature

Who cites it

447 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Mucosal immune response in biology, disease prevention and treatment.Signal transduction and targeted therapy · 2025
    Pooled it
  2. Pooled it
  3. Pooled it
  4. A nasal airflow oscillation device targeting nasal congestion: a preliminary report.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2024
    Trial
  5. Review
  6. Article
  7. Epigenetic regulation and chromatin organization in cystic fibrosis airways.Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2026
    Review
  8. Article
  9. Article
  10. Mucins and Respiratory Virus Infection.Annual review of virology · 2026
    Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Structural and cellular mechanisms of mucus plugging in the larger airways.Chinese medical journal pulmonary and critical care medicine · 2026
    Review
  18. Investigating human lung resilience, its evolutionary history and its relation to COPD.American journal of physiology. Lung cellular and molecular physiology · 2026
    Review
  19. Article
  20. Article

387 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Brian ButtonCystic Fibrosis Research and Treatment Center, University of North Carolina, Chapel Hill, NC 27599-7248, USA.
Li-Heng Cai
Camille Ehre
Mehmet Kesimer
David B Hill
John K Sheehan
Richard C Boucher
Michael Rubinstein

Funding

UNC CLINICAL AND TRANSLATIONAL SCIENCE AWARD: BPCAUL1RR025747 · NCRR · UNIV OF NORTH CAROLINA CHAPEL HILL · PI RUNGE, MARSCHALL S. · 2008 to 2011
$44.6M
Vector CoreP30DK065988 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Martina Gentzsch · 2004 to 2026
$26.5M
The Biophysics of Mucus Hydration and Adhesion/CohesionP01HL108808 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI PEDEN, DAVID B. · 2012 to 2021
$23.9M
The Role of Airway Surface Liquid Nucleotides/Nucleosides in Volume HomeostasisP01HL034322 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BOUCHER, RICHARD CHARLES · 1986 to 2011
$22.1M
Purinergic Control of CFTR-ENaC Interactions in Alveolar EpitheliaP01HL110873 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BOUCHER, RICHARD CHARLES · 2012 to 2016
$10.7M
Virtual Lung Project: Integrated Modeling of EpithelialR01HL077546 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SUPERFINE, RICHARD · 2006 to 2010
$3.6M
The role of mucin-protein interactions in the innate defense of the lungR01HL103940 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KESIMER, MEHMET · 2010 to 2014
$1.8M
Mucus Adhesion to Epithelial Cells and its Mobilization in COPD and CFP50HL107168 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BOUCHER, RICHARD CHARLES, DOERSCHUK, CLAIRE M · 2011 to 2012
$885k
Mechanotransduction of shear stress: from ATP release to CFTR regulationK01DK080847 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BUTTON, BRIAN M · 2008 to 2010
$301k
NCRR NIH HHS UL1 RR025747NCRR NIH HHS UL1-RR025747NHLBI NIH HHS HHSN268200900020CNHLBI NIH HHS P01 HL034322NHLBI NIH HHS P01 HL108808NHLBI NIH HHS P01HL108808NHLBI NIH HHS P01 HL110873NHLBI NIH HHS P01HL110873-01NHLBI NIH HHS P01HL34322NHLBI NIH HHS P50 HL107168NHLBI NIH HHS P50HL107168NHLBI NIH HHS P50HL107168-01NHLBI NIH HHS R01 HL077546NHLBI NIH HHS R01HL077546NHLBI NIH HHS R01 HL103940NHLBI NIH HHS R01HL103940NIDDK NIH HHS K01 DK080847NIDDK NIH HHS K01DK080847NIDDK NIH HHS P30 DK065988NIDDK NIH HHS P30DK065988PHS HHS HHSN268200900020
6 · The paper itself

Abstract

Mucus clearance is the primary defense mechanism that protects airways from inhaled infectious and toxic agents. In the current gel-on-liquid mucus clearance model, a mucus gel is propelled on top of a "watery" periciliary layer surrounding the cilia. However, this model fails to explain the formation of a distinct mucus layer in health or why mucus clearance fails in disease. We propose a gel-on-brush model in which the periciliary layer is occupied by membrane-spanning mucins and mucopolysaccharides densely tethered to the airway surface. This brush prevents mucus penetration into the periciliary space and causes mucus to form a distinct layer. The relative osmotic moduli of the mucus and periciliary brush layers explain both the stability of mucus clearance in health and its failure in airway disease.

Indexed as

Models, BiologicalMucociliary ClearanceCells, CulturedCiliaGelsGlycosaminoglycansHumansLungLung DiseasesMucinsMucusOsmotic PressureRespiratory MucosaGelsGlycosaminoglycansMucins

Identifiers

PMID22923574
PMCPMC3633213

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.